Organigram Holdings Inc.’s (TSX: OGI) (NASDAQ: O
Post# of 88
(Total Views: 308)
Posted On: 08/28/2019 5:31:00 PM
Organigram Holdings Inc.’s (TSX: OGI) (NASDAQ: OGI) Commitment to Corporate Governance, Fiscal Discipline a ‘Rarity in the Industry’
- Organigram’s corporate governance distinguishes the company in the cannabis industry
- OGI’s consistent financial performance positions it as an “anomaly in the Canadian cannabis market”
- The company recently upgraded from the TSX Venture Exchange to the Toronto Stock Exchange
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian licensed producer (LP) of premium-quality cannabis and extract-based products, is focused on producing high-quality, indoor-grown cannabis for patients and adult-recreational consumers. Championing that cause is Organigram’s leadership team, a group of seasoned professionals on the forefront of the global cannabis market who bring decades of experience in consumer-packaged goods, and pharma, including a CEO who held the same position at Tilray (NASDAQ: TLRY) before joining Organigram. In addition, the company’s fiscal discipline and execution, as well as its solid corporate governance foundation, distinguish it while some other LPs have met mild to severe consequences for regulatory breaches.
Bloomberg noted that OGI has a fully independent board of directors (excluding CEO Greg Engel), which is a rarity in the cannabis sector. The CEO sees good corporate governance as essential to a well-run pot company. “This is an industry that’s still very much moving from founders and executives being chairmen or multiple insiders on boards,” Engel told Bloomberg (http://nnw.fm/YXap1). “I think some of the challenges we’ve seen in the industry have been because of a lack of governance. You have to have independent governance that has oversight and holds management accountable.”
Along with the company’s impressive corporate governance comes its equally notable — and consistent — financial performance. This is likely due to its team’s adherence to fiscal discipline, something that can be difficult to find in this industry. Bloomberg noted that, with four quarters of profitability under its belt, Organigram Holdings is “an anomaly in the Canadian cannabis market.”
“Organigram has higher margins than most of its peers and one of the lowest costs per gram in the industry even though it grows indoors, generally considered the most expensive method of production,” the report stated. “Chief Executive Officer Greg Engel attributes this to its ability to get higher yields from its pot plants than companies that grow in greenhouses, as well as its automated packaging lines. No other large Canadian pot producer has managed to post such a long string of positive EBITDA.”
In addition, the company recently uplisted to the Toronto Stock Exchange (TSX) from the TSX Venture Exchange (TSX.V) under the symbol ‘OGI’.
“Graduating to the TSX is a significant milestone for us as a corporation,” Engel stated in a news release (http://nnw.fm/K9xnd). “Our stakeholders have an eye on this marketplace, and this graduation will broaden our reach within the investment community and encourage new investors to learn more about our business, our growth plans and corporate objectives.”
As a result of many of these developments, OGI has attracted significant attention. OGI was deemed a “compelling cannabis stock to buy in August” in a recent article distributed by The Motley Fool (http://nnw.fm/6T8Un). “I continue to view the long-term prospects for Organigram in a favorable light,” contributor Keith Speights wrote. “Other Canadian cannabis producers get a lot more hype right now, but Organigram could be a rising star that will attract plenty of attention in the near future. What I really like about Organigram is that its management team exercises fiscal discipline, which is kind of a rarity in the industry.”
Organigram’s primary facility is located in Moncton, New Brunswick, and the company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). Organigram has sales in all 10 Canadian provinces. The company has developed a portfolio of legal, adult-use recreational cannabis brands, including The Edison Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer. Additionally, it delivers industry-leading yields and maximizes quality-cannabis production at one of the lowest cultivation costs per gram* among publicly reporting Canadian LPs. Organigram is committed to translating operational excellence into strong financial results and return on investment for shareholders.
* Cultivation cost per gram is a non-IFRS measure. Please see the Company’s latest MD&A.
For more information, visit the company’s website at www.Investors.Organigram.ca
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- Organigram’s corporate governance distinguishes the company in the cannabis industry
- OGI’s consistent financial performance positions it as an “anomaly in the Canadian cannabis market”
- The company recently upgraded from the TSX Venture Exchange to the Toronto Stock Exchange
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian licensed producer (LP) of premium-quality cannabis and extract-based products, is focused on producing high-quality, indoor-grown cannabis for patients and adult-recreational consumers. Championing that cause is Organigram’s leadership team, a group of seasoned professionals on the forefront of the global cannabis market who bring decades of experience in consumer-packaged goods, and pharma, including a CEO who held the same position at Tilray (NASDAQ: TLRY) before joining Organigram. In addition, the company’s fiscal discipline and execution, as well as its solid corporate governance foundation, distinguish it while some other LPs have met mild to severe consequences for regulatory breaches.
Bloomberg noted that OGI has a fully independent board of directors (excluding CEO Greg Engel), which is a rarity in the cannabis sector. The CEO sees good corporate governance as essential to a well-run pot company. “This is an industry that’s still very much moving from founders and executives being chairmen or multiple insiders on boards,” Engel told Bloomberg (http://nnw.fm/YXap1). “I think some of the challenges we’ve seen in the industry have been because of a lack of governance. You have to have independent governance that has oversight and holds management accountable.”
Along with the company’s impressive corporate governance comes its equally notable — and consistent — financial performance. This is likely due to its team’s adherence to fiscal discipline, something that can be difficult to find in this industry. Bloomberg noted that, with four quarters of profitability under its belt, Organigram Holdings is “an anomaly in the Canadian cannabis market.”
“Organigram has higher margins than most of its peers and one of the lowest costs per gram in the industry even though it grows indoors, generally considered the most expensive method of production,” the report stated. “Chief Executive Officer Greg Engel attributes this to its ability to get higher yields from its pot plants than companies that grow in greenhouses, as well as its automated packaging lines. No other large Canadian pot producer has managed to post such a long string of positive EBITDA.”
In addition, the company recently uplisted to the Toronto Stock Exchange (TSX) from the TSX Venture Exchange (TSX.V) under the symbol ‘OGI’.
“Graduating to the TSX is a significant milestone for us as a corporation,” Engel stated in a news release (http://nnw.fm/K9xnd). “Our stakeholders have an eye on this marketplace, and this graduation will broaden our reach within the investment community and encourage new investors to learn more about our business, our growth plans and corporate objectives.”
As a result of many of these developments, OGI has attracted significant attention. OGI was deemed a “compelling cannabis stock to buy in August” in a recent article distributed by The Motley Fool (http://nnw.fm/6T8Un). “I continue to view the long-term prospects for Organigram in a favorable light,” contributor Keith Speights wrote. “Other Canadian cannabis producers get a lot more hype right now, but Organigram could be a rising star that will attract plenty of attention in the near future. What I really like about Organigram is that its management team exercises fiscal discipline, which is kind of a rarity in the industry.”
Organigram’s primary facility is located in Moncton, New Brunswick, and the company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). Organigram has sales in all 10 Canadian provinces. The company has developed a portfolio of legal, adult-use recreational cannabis brands, including The Edison Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer. Additionally, it delivers industry-leading yields and maximizes quality-cannabis production at one of the lowest cultivation costs per gram* among publicly reporting Canadian LPs. Organigram is committed to translating operational excellence into strong financial results and return on investment for shareholders.
* Cultivation cost per gram is a non-IFRS measure. Please see the Company’s latest MD&A.
For more information, visit the company’s website at www.Investors.Organigram.ca
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)